These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 3104707

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G, Hopkins A, Akbar FA.
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [Abstract] [Full Text] [Related]

  • 5. Medical treatment of peptic ulcers.
    Deveney CW, Deveney KE.
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Omeprazole in the therapy of acid-induced diseases].
    Simon B, Dammann HG, Müller P.
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prostaglandin treatment for peptic ulcer.
    Walt RP.
    Scand J Gastroenterol Suppl; 1988 Aug; 146():40-9. PubMed ID: 2906468
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Stomach ulcer healing with enprostil, an orally effective prostaglandin E2 analog: direct comparative study with ranitidine].
    Hüttemann W, Beckenbach HP, Daake H, Dammann HG, Jancke T, Kalek HD, Kühn V, Martens W, Müller P, Rohner HG.
    Z Gastroenterol; 1986 May; 24(5):252-6. PubMed ID: 3088859
    [Abstract] [Full Text] [Related]

  • 12. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ, Agrawal NM.
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Addition of misoprostol to ranitidine in non-responders to H2-blockers and pirenzepine.
    Walker S, Sarem-Aslani A, Treiber G, Klotz U, Bode JC.
    Neth J Med; 1991 Feb; 38(1-2):18-23. PubMed ID: 1674363
    [Abstract] [Full Text] [Related]

  • 15. Cytoprotection of gastroduodenal mucous membrane with analogues of prostaglandins.
    Lauritsen K, Laursen LS, Rask-Madsen J.
    Recenti Prog Med; 1989 Jun; 80(6):344-52. PubMed ID: 2672199
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandins and peptic ulcer therapy.
    Walt RP.
    Scand J Gastroenterol Suppl; 1990 Jun; 174():29-36. PubMed ID: 1976271
    [Abstract] [Full Text] [Related]

  • 17. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; prostaglandins].
    Arakawa T, Kobayashi K.
    Nihon Rinsho; 1988 Jan; 46(1):64-8. PubMed ID: 3131560
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Jan; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [Abstract] [Full Text] [Related]

  • 20. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK, Mahakian K, Trudeau WT.
    Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.